课题基金 / 基金详情

IL-16 regulates mast cell chemotaxis and function through the tetraspanin CD9.

IL-16 regulates mast cell chemotaxis and function through the tetraspanin CD9.
IL-16 通过四跨膜蛋白 CD9 调节肥大细胞趋化性和功能。
批准号:
nhmrc : 300431
负责人:
Prof Steven Krilis
金额:
$31.06万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2006-12-31
关键词:

项目摘要

项目成果

Prof Steven Krilis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mast cells are found in humans and other mammals at strategic sites such as skin, lining of the airways and gut and provide a first line of defence against a variety of infections. These cells use a number of products that have profound effects in humans. In particular, these products are thought to be involved in defence against bacteria, viruses and are implicated in allergic conditions such as asthma. In normal circumstances mast cells are only found in the tissues and not in the peripheral blood. However, we have made the first observation that mast-like cells occur in the peripheral blood of patients with asthma and allergic conditions but not in normals. This finding changed the prevailing paradigm for mast cell biology. The products that can influence mast cell growth and function are vital to the understanding of how mast cells are involved in conditions such as human asthma. We have demonstrated that a protein (CD9) on mast cells in the tetraspanin family is a receptor for a product (IL-16) which is thought to be important in asthma and other inflammatory conditions. The understanding of how mast cells are regulated by IL-16 may lead to potential new therapies in conditions such as asthma and HIV-1 infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineation of the role of RasGRP4 in mast cell growth, differentiation and activation, using RasGRP4 deficient mice
  • 批准号:
    nhmrc : 630402
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $42.42万
  • 财政年份:
    2010
  • 负责人:
    Prof Steven Krilis
  • 依托单位:
Pathophysiological Mechanisms in the Antiphospholipid Syndrome: B2GPI Regulation of FXI-FXIa
  • 批准号:
    nhmrc : 510130
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $35.38万
  • 财政年份:
    2008
  • 负责人:
    Prof Steven Krilis
  • 依托单位:
The role of RasGRP4, a mast cell specific protein in mast cell growth, differentiation and activation
  • 批准号:
    nhmrc : 455201
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $38.7万
  • 财政年份:
    2007
  • 负责人:
    Prof Steven Krilis
  • 依托单位:
Antiphospholipid Antibodies, Beta 2-Glycoprotein I and control of coagulation.
  • 批准号:
    nhmrc : 350846
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.41万
  • 财政年份:
    2005
  • 负责人:
    Prof Steven Krilis
  • 依托单位:
国内基金
海外基金
CXCR6/CXCL16-NLRP3炎症小体调控巨噬细胞M1极化促进血管钙化的机制研究
  • 批准号:
    JCZRLH202600058
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
METTL16通过m6A修饰调控miR-181a-5p/PHOX2B信号通路抑制神经母细胞瘤进展的作用机制
  • 批准号:
    2026JJ82033
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘登辉
  • 依托单位:
间充质干细胞通过调控 CXCL16/CXCR6-EGFR-自噬轴缓解放射性直肠损伤纤维化的机制研究
  • 批准号:
    2026JJ50608
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    屈展
  • 依托单位:
ADAMTS1靶向MDM2/RBM15/hnRNPC/p16轴诱导心脏衰老的作用机制研究
  • 批准号:
    2026JJ81629
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    蒋路平
  • 依托单位: